Piper Jaffray analyst, Matt O'Brien, was positive on NxStage Medical (NASDAQ: NXTM) related to Baxter's CEO announcing the cancelling of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE